Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Zhanke He"'
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-16 (2020)
Abstract Background Tumors display a high rate of glucose metabolism and the SLC2A (also known as GLUT) gene family may be central regulators of cellular glucose uptake. However, roles of SLC2A family in mechanism of metabolite communication with imm
Externí odkaz:
https://doaj.org/article/5846fd1729264912b839351b68aaa4e8
Autor:
Guangyan Wu, Mengwei Niu, Wenli Tang, Jingjuan Hu, Guoquan Wei, Zhanke He, Yangping Chen, Yong Jiang, Peng Chen
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Background l-Fucose (Fuc), a six-deoxy hexose monosaccharide, is present endogenously in humans and animals and has a wide range of biological functions. In the present study, we aimed to examine the effect of Fuc on obesity and hepatic stea
Externí odkaz:
https://doaj.org/article/867d210dcc494fa69dccc8effeb79fa5
Autor:
Guangyan Wu, Mengwei Niu, Wenli Tang, Jingjuan Hu, Guoquan Wei, Zhanke He, Yangping Chen, Yong Jiang, Peng Chen
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/a73e6837d33f4e50a58d398bc5c6084d
Publikováno v:
Sensors, Vol 14, Iss 10, Pp 18878-18885 (2014)
As a network transmission protocol, Networked Transport of RTCM via Internet Protocol (NTRIP) is widely used in GPS and Global Orbiting Navigational Satellite System (GLONASS) Augmentation systems, such as Continuous Operational Reference System (COR
Externí odkaz:
https://doaj.org/article/4d2fdd23715640469e968d85649ed5f0
Publikováno v:
Advances in Space Research. 71:3968-3980
Autor:
Xingxing Yao, Zhanke He, Caolitao Qin, Penghao Zhang, Chuyang Sui, Xiangqian Deng, Yuxin Fang, Guoxin Li, Jiaolong Shi
Publikováno v:
Br J Cancer
BACKGROUND: Multiple mechanisms have been proposed that lead to reduced effectiveness of trastuzumab in HER2-positive gastric cancer (GC), yet resistance to trastuzumab remains a challenge in clinics. METHODS: We established trastuzumab-resistant cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd2755bc3a1d431c5714c0912a970a38
https://europepmc.org/articles/PMC9427959/
https://europepmc.org/articles/PMC9427959/
Autor:
Zhanke He, Junbo Yang, Chuyang Sui, Penghao Zhang, Ting Wang, Tingyu Mou, Kai Sun, Yanan Wang, Zhijun Xu, Guoxin Li, Haijun Deng, Jiaolong Shi, Baoxiong Zhuang
Publikováno v:
Archives of biochemistry and biophysics. 722
FAM98A is a microtubule-associated protein involved in cell proliferation and migration, and is frequently dysregulated in epithelial cancers. But its role in the development of colorectal cancer (CRC) cancer remains unknown.Immunohistochemical analy
Autor:
Fangzhao Wang, Tanwei Gu, Shenhai Gong, Jun Wang, Aihua Liu, Guoquan Wei, Mengwei Niu, Zhanke He, Yong Jiang, Peng Chen
Publikováno v:
Biochemical and Biophysical Research Communications. 508:1004-1010
Sepsis is a serious condition with a high mortality rate worldwide. Granisetron is an anti-nausea drug for patients undergoing chemotherapy. Here we aimed to identify the novel effect of granisetron on sepsis-induced acute lung injury (ALI). Our resu
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-16 (2020)
Cancer Cell International
Cancer Cell International
Background Tumors display a high rate of glucose metabolism and the SLC2A (also known as GLUT) gene family may be central regulators of cellular glucose uptake. However, roles of SLC2A family in mechanism of metabolite communication with immunity in
Autor:
Zhanke He, Jiaolong Shi, Xingxing Yao, Chu-Yang Sui, Zechang Chen, Da Chen, Guoxin Li, Penghao Zhang, Jiani Wu, Xiangqian Deng, Jiang Yu, Diankun Liu
Publikováno v:
Archives of biochemistry and biophysics. 702
The antimetabolite 5-fluorouracil (5-FU) is a widely used chemotherapy regimen for the treatment of gastric cancer (GC). However, resistance to 5-FU remains a major drawback in the clinical use. The treatments of anti-tumor chemo-agents recruit tumor